These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25129079)
1. [NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?]. Ozono S; Hinotsu S; Namiki M; Akaza H Gan To Kagaku Ryoho; 2014 Jun; 41(6):683-6. PubMed ID: 25129079 [TBL] [Abstract][Full Text] [Related]
2. What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)? Akaza H Jpn J Clin Oncol; 2016 Apr; 46(4):299-302. PubMed ID: 26830151 [TBL] [Abstract][Full Text] [Related]
3. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer. Nishiyama H Jpn J Clin Oncol; 2018 Jan; 48(1):3-6. PubMed ID: 29145591 [TBL] [Abstract][Full Text] [Related]
4. NCCN Asia Consensus Statement prostate cancer. Hinotsu S; Namiki M; Ozono S; Akaza H Jpn J Clin Oncol; 2018 Nov; 48(11):964-965. PubMed ID: 30184146 [TBL] [Abstract][Full Text] [Related]
5. The NCCN Guidelines Development Program. Winn RJ; Botnick W; Dozier N Oncology (Williston Park); 1996 Nov; 10(11 Suppl):23-8. PubMed ID: 8953592 [TBL] [Abstract][Full Text] [Related]
6. NCCN and ACS collaborate on a patient's version of the NCCN practice guidelines for breast cancer. National Comprehensive Cancer Network. American Cancer Society. Rose VL Am Fam Physician; 1999 Nov; 60(7):2169-70. PubMed ID: 10569514 [No Abstract] [Full Text] [Related]
7. Consensus recommendations for management of head and neck cancer in Asian countries: a review of international guidelines. D'cruz A; Lin T; Anand AK; Atmakusuma D; Calaguas MJ; Chitapanarux I; Cho BC; Goh BC; Guo Y; Hsieh WS; Hu C; Kwong D; Lin JC; Lou PJ; Lu T; Prabhash K; Sriuranpong V; Tang P; Vu VV; Wahid I; Ang KK; Chan AT Oral Oncol; 2013 Sep; 49(9):872-877. PubMed ID: 23830839 [TBL] [Abstract][Full Text] [Related]
8. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Korman H; Lanni T; Shah C; Parslow J; Tull J; Ghilezan M; Krauss D; Balaraman S; Kernen K; Cotant M; Margolis J; Vicini FA Am J Clin Oncol; 2013 Apr; 36(2):121-5. PubMed ID: 22307214 [TBL] [Abstract][Full Text] [Related]
9. Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Williams S; Chiong E; Lojanapiwat B; Umbas R; Akaza H; Lancet Oncol; 2013 Nov; 14(12):e524-34. PubMed ID: 24176571 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer: the current evidence and guidelines controversy. Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148 [TBL] [Abstract][Full Text] [Related]
11. Update of the NCCN guidelines for treatment of prostate cancer. Millikan R; Logothetis C Oncology (Williston Park); 1997 Nov; 11(11A):180-93. PubMed ID: 9430189 [No Abstract] [Full Text] [Related]
12. Kidney Cancer Working Group report. Naito S; Tomita Y; Rha SY; Uemura H; Oya M; Song HZ; Zhong LH; Wahid MI Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i51-56. PubMed ID: 20870920 [TBL] [Abstract][Full Text] [Related]